mRNA Platform Technology - SmartCap / STLNP

1. Generic ST Pharm focusing on technical challenging and brand generics. We specialize in MRI contrast agents and and possess a portfolio of tuberculosis and anti-infectious drugs as generic APIs. 2. Monomer ST Pharm offers a one-stop service from nucleosides to phosphoramidites with specialty and commo...

ST Pharm provides mRNA CDMO service from custom mRNA IVT synthesis to lipid nanoparticle (LNP) formulation with its own IP on two key mRNA platform technologies, SmartCap (proprietary 5'-capping) and STLNP (LNP with novel ionizable lipid). We are able to manufacture in GMP/non-GMP grade, and able to suppo...

The expansion is expected to make the company the largest CDMO in oligonucleotide production in 2025

ST Pharm, we are the innovative company saving lives. As a reliable CDMO partner, ST Pharm offers comprehensive contract development and manufacturing services. As your trusted partner, we will take you on a journey to explore the core values and capabilities that define our company.